226 related articles for article (PubMed ID: 18070237)
1. Proton pump inhibitors and the risk of colorectal cancer.
van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
[TBL] [Abstract][Full Text] [Related]
2. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
3. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use.
Siersema PD; Yu S; Sahbaie P; Steyerberg EW; Simpson PW; Kuipers EJ; Triadafilopoulos G
Gastrointest Endosc; 2006 Apr; 63(4):581-6. PubMed ID: 16564855
[TBL] [Abstract][Full Text] [Related]
4. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
Kaye JA; Jick H
Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.
Robertson DJ; Larsson H; Friis S; Pedersen L; Baron JA; Sørensen HT
Gastroenterology; 2007 Sep; 133(3):755-60. PubMed ID: 17678921
[TBL] [Abstract][Full Text] [Related]
7. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
8. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
[TBL] [Abstract][Full Text] [Related]
9. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
10. Chronic statin therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290
[TBL] [Abstract][Full Text] [Related]
11. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study.
Mulder SA; van Soest EM; Dieleman JP; van Rossum LG; Ouwendijk RJ; van Leerdam ME; Kuipers EJ
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):437-43. PubMed ID: 19952765
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):855-61. PubMed ID: 19465157
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
14. Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.
McGowan B; Bennett K; Barry M
Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):763-9. PubMed ID: 20582909
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
16. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
[TBL] [Abstract][Full Text] [Related]
17. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
[TBL] [Abstract][Full Text] [Related]
18. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
Suh DC; Hunsche E; Shin HC; Mavros P
Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
[TBL] [Abstract][Full Text] [Related]
19. Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Causes Control; 2008 Feb; 19(1):67-74. PubMed ID: 17943453
[TBL] [Abstract][Full Text] [Related]
20. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
